Left-sided colorectal cancer
Clinical trials for Left-sided colorectal cancer explained in plain language.
Never miss a new study
Get alerted when new Left-sided colorectal cancer trials appear
Sign up with your email to follow new studies for Left-sided colorectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo aims to outperform standard therapy in Tough-to-Treat colorectal cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug called petosemtamab, combined with chemotherapy, works better than the current standard treatment (cetuximab plus chemotherapy) for people with left-sided colorectal cancer that cannot be surgically removed or has spread. The study incl…
Matched conditions: LEFT-SIDED COLORECTAL CANCER
Phase 3 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New hope for colorectal cancer: amivantamab combo tested in 1,000 patients
Disease control Recruiting nowThis study compares two drug combinations for people with advanced left-sided colorectal cancer that cannot be removed by surgery. Participants receive either amivantamab or cetuximab along with chemotherapy. The goal is to see which combination helps keep the cancer from growing…
Matched conditions: LEFT-SIDED COLORECTAL CANCER
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC